Ubidecarenone and Flatulence - a phase IV clinical study of FDA data

Summary:

Flatulence is reported as a side effect among people who take Ubidecarenone (coenzyme q - 10), especially for people who are female, 60+ old, also take Melatonin, and have Insomnia.

The phase IV clinical study analyzes which people have Flatulence when taking Ubidecarenone. It is created by eHealthMe based on reports of 3,367 people who have side effects when taking Ubidecarenone from the FDA, and is updated regularly.

What is Ubidecarenone?

Ubidecarenone has active ingredients of coenzyme q - 10. eHealthMe is studying from 3,373 Ubidecarenone users. Check the latest studies of Ubidecarenone.

What is Flatulence?

Flatulence (flatus expelled through the anus) is found to be associated with 1,759 drugs and 1,892 conditions by eHealthMe. Check the latest studies of Flatulence.

On Jul, 14, 2026

3,367 people reported to have side effects when taking Ubidecarenone.
Among them, 33 people (0.98%) have Flatulence.

Among these 33 people:

What is the gender of people who have Flatulence when taking Ubidecarenone? *

female: 65.62 %
male: 34.38 %

What is the age of people who have Flatulence when taking Ubidecarenone? *

What are other drugs people take besides Ubidecarenone? *

What are other side effects people have besides Flatulence? *

Diarrhea: 18 people, 54.55%
Weakness: 12 people, 36.36%
Rashes (redness): 12 people, 36.36%
Abdominal Distension: 11 people, 33.33%
Nausea (feeling of having an urge to vomit): 10 people, 30.30%
Back Pain: 9 people, 27.27%
Fatigue (feeling of tiredness): 9 people, 27.27%
Joint Pain: 9 people, 27.27%
Itching: 9 people, 27.27%
Pain: 8 people, 24.24%

What are the existing conditions these people have? *

Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 15.15%
Insomnia (sleeplessness): 5 people, 15.15%
Weakness: 4 people, 12.12%
Neurodegenerative Disorder (progressive loss of structure or function of neurons and death of neuron): 4 people, 12.12%
Bone Disorder: 4 people, 12.12%
Cardiac Disorder: 4 people, 12.12%
Connective Tissue Disorder (any disease that has the connective tissues of the body): 4 people, 12.12%
Constipation: 4 people, 12.12%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 4 people, 12.12%
Gastrointestinal Motility Disorder (abnormal intestinal contractions): 4 people, 12.12%

* Approximation only. Some reports may have incomplete information.

Do you take Ubidecarenone and have Flatulence?

- Check whether Flatulence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ubidecarenone:

Ubidecarenone (3,373 reports)

Flatulence treatments and more:

Flatulence (70,667 reports)

Browse all side effects of Ubidecarenone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Flatulence:

Flatulence (1,759 drugs)

Browse all the conditions that are associated with Flatulence:

Flatulence (1,892 conditions)

Related publications that referenced our studies

Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 (the active ingredients of Ubidecarenone) and Ubidecarenone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.